Evidence map›Paper›PMID 34471030›Full record

ArticleInternal medicine (Tokyo, Japan)2022

The "Ant-farm"-like Appearance of Restricted Lower Limb Vasculitis on Fluorodeoxyglucose-positron Emission Tomography.

Shintaro Yamamoto, Tomoyuki Mukai, Shunichi Fujita, Yuka Koide, Yumika Ono, Masayuki Inubushi, Hirotake Nishimura, Asami Munekane, Yoshitaka Morita

Open access · diamondAbstract read
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Shintaro YamamotoDepartment of Rheumatology, Kawasaki Medical School, Japan.
Tomoyuki MukaiDepartment of Rheumatology, Kawasaki Medical School, Japan.
Shunichi FujitaDepartment of Rheumatology, Kawasaki Medical School, Japan.
Yuka KoideDepartment of Rheumatology, Kawasaki Medical School, Japan.
Yumika OnoDepartment of Nuclear Medicine, Kawasaki Medical School, Japan.
Masayuki InubushiDepartment of Nuclear Medicine, Kawasaki Medical School, Japan.
Hirotake NishimuraDepartment of Pathology, Kawasaki Medical School, Japan.
Asami MunekaneDepartment of Neurology, Kawasaki Medical School, Japan.
Yoshitaka MoritaDepartment of Rheumatology, Kawasaki Medical School, Japan.
Kawasaki Medical School · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Restricted lower limb vasculitis is a type of localized muscle vasculitis limited to the lower limbs. The usefulness of fluorodeoxyglucose-positron emission tomography (FDG-PET) for the diagnosis of this entity has not yet been reported. We herein report three patients with a fever and persistent lower limb pain. FDG-PET revealed linear and patchy FDG uptakes in their lower limbs. Combined with magnetic resonance imaging and histological findings, they were diagnosed with lower limb vasculitis. Linear and patchy FDG uptakes are considered to reflect the presence of muscle vasculitis. The characteristic "ant-farm"-like FDG-PET images can be a diagnostic clue for the currently overlooked vasculitis.

Indexed as

VasculitisFluorodeoxyglucose F18HumansLower ExtremityPositron-Emission TomographyPositron Emission Tomography Computed TomographyRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsFDG-PETfevermuscle vasculitismyalgiarestricted lower limb vasculitis

Identifiers

PMID34471030
PMCPMC8987253
OpenAlexW3198495643

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.